Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02285959
Title Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Erol Veznedaroglu
Indications

glioblastoma

Therapies

Bevacizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.